Open Letter to the FDA, by Sandro Rasman, 7th August 2012

Dear Mr. Silverman,

I am writing to thank you for the alert issued by the FDA on May 10, 2012, on Chronic Cerebrospinal Venous Insufficiency (CCSVI) and multiple sclerosis (MS). I was treated and had some improvement in my symptoms and quality of life. I have some concerns that I hope you will consider as you continue to regulate this procedure.

1)Your warning did not reference the four safety studies on CCSVI by Zamboni, Petrov, Simka, and Mandato. It was therefore biased in favor of the pharmaceutical approach to this mysterious disease. Judging from the medical news reports following your warning, it seems that FDA fostered a misunderstanding in the medical community about CCSVI that will needlessly delay research. To be more balanced and accurate, your warning should consider:.....................

read the entire letter: http://www.facebook.com/notes/sandro-rasman/open-letter-to-the-fda/506654626015676?notif_t=note_tag


Open Letter to the FDA
Dear Mr. Silverman,   I am writing to thank you for the alert issued by the FDA on May 10, 2012, on Chronic Cerebrospinal Venous Insufficiency (CCSVI) and multiple sclerosis (MS). I was treated and had some improvement in my symptoms and quality of life....